Vilazodone (Viibryd)

Vilazodone is an antidepressant used in Canada for the symptomatic treatment of major depressive disorder (MDD) in adults. Unlike a conventional SSRI, vilazodone has two important serotonergic actions:

1. It blocks SERT — the serotonin transporter

and:

2. It partially activates 5-HT1A serotonin receptors

Because of this combination, vilazodone is sometimes described pharmacologically as a serotonin partial agonist-reuptake inhibitor (SPARI), although this is a descriptive pharmacology term rather than a separate Health Canada drug class.

The simplified mechanism is:

Vilazodone

• SERT inhibition
• 5-HT1A partial agonism

1. Serotonin signaling changes
2. Mood and emotional-regulation networks gradually adapt
3. Depressive symptoms may improve

The current Canadian product monograph identifies vilazodone as both a selective serotonin-reuptake inhibitor and a 5-HT1A partial agonist.

What Is Vilazodone Used For?

In Canada, vilazodone is approved for: Major Depressive Disorder — MDD in adults.

Symptoms of depression may include:

• Persistent low mood
• Loss of interest or pleasure
• Reduced energy
• Difficulty concentrating
• Changes in sleep
• Changes in appetite
• Reduced motivation
• Negative or repetitive thinking Canadian labeling states that vilazodone’s short-term efficacy was demonstrated in trials lasting approximately 8–10 weeks. The current monograph notes that long-term maintenance efficacy has not been established and recommends periodically reassessing continued treatment.

Vilazodone is not approved in Canada for bipolar depression.

Is Vilazodone Available in Canada?

Yes.

Health Canada currently lists branded Viibryd 10 mg, 20 mg and 40 mg as marketed. Generic APO-Vilazodone 10 mg, 20 mg and 40 mg is also marketed in Canada.

Vilazodone is a:

Prescription medication

and is taken orally once daily.

Is Vilazodone Approved for Children?

No.

Health Canada has not authorized vilazodone for patients:

Under 18 years of age

because efficacy has not been established in pediatric major depressive disorder.

How Does Vilazodone Work?

Vilazodone has two principal actions.

SERT Inhibition- Serotonin Transporter and is encoded by: SLC6A4

Normally:

1. Serotonin released
2. Serotonin stimulates receptors
3. SERT transports serotonin back into the neuron

Vilazodone blocks SERT:

1. Vilazodone
2. SERT inhibited
3. Serotonin reuptake decreases
4. Serotonin remains available longer between neurons

Vilazodone has very high affinity for the serotonin-reuptake site and is much less potent at norepinephrine or dopamine reuptake.

What Does 5-HT1A Partial Agonism Mean?

Vilazodone also directly binds to: 5-HT1A Serotonin Receptors and acts as a: Partial agonist

A partial agonist stimulates a receptor but generally produces less receptor activation than a full agonist.

Therefore:

1. Vilazodone
2. 5-HT1A partially activated

while simultaneously:

1. SERT is inhibited
2. Serotonin-system regulation changes through two mechanisms

The precise contribution of 5-HT1A partial agonism to vilazodone’s antidepressant effect is not fully established, but it differentiates vilazodone pharmacologically from conventional SSRIs such as sertraline, citalopram and paroxetine.

Does Vilazodone Increase Serotonin?

Yes, indirectly.

It does not primarily make the brain manufacture additional serotonin.

Instead:

1. Vilazodone inhibits SERT
2. Serotonin is removed more slowly from the synapse
3. Extracellular serotonin signaling increases

At the same time, vilazodone directly influences:

5-HT1A receptors

This gives it a broader serotonergic mechanism than a pure serotonin-reuptake inhibitor.

Does Vilazodone Increase Dopamine?

Not significantly through direct dopamine-transporter inhibition.

Vilazodone is much more selective for: Serotonin reuptake than for: Dopamine reuptake or:

Norepinephrine reuptake.

It should therefore be regarded primarily as a:

Serotonergic antidepressant rather than as a dopamine-enhancing medication.

Serotonin and dopamine systems interact, so indirect downstream dopamine effects may occur in certain brain regions.

Does Vilazodone Increase Norepinephrine?

Not substantially through direct NET inhibition.

Vilazodone has much weaker affinity for:

NET — Norepinephrine Transporter

than for SERT.

It is therefore not an SNRI like:

• Venlafaxine
• Desvenlafaxine
• Duloxetine
• Levomilnacipran Its principal pharmacology remains:

SERT inhibition + 5-HT1A partial agonism

How Long Does Vilazodone Take to Work?

The Canadian monograph states that therapeutic response is often seen within approximately:

1–2 weeks

but this should not be interpreted as meaning that full antidepressant benefit necessarily occurs that quickly. Depression commonly continues improving over several additional weeks.

The process is:

1. Vilazodone started
2. SERT inhibited + 5-HT1A affected
3. Serotonin signaling changes rapidly
4. Receptors, feedback systems and neural networks adapt
5. Clinical improvement develops gradually

What Are the Common Side Effects of Vilazodone?

The most characteristic vilazodone side effects are gastrointestinal.

Common or important effects include:

• Diarrhea
• Nausea
• Headache
• Dizziness
• Insomnia
• Sleepiness
• Dry mouth
• Vomiting
• Abdominal discomfort
• Restlessness
• Abnormal dreams
• Sexual dysfunction In pooled Canadian placebo-controlled trials, diarrhea occurred in approximately 28.1% of vilazodone-treated patients versus 9.5% with placebo, while nausea occurred in approximately 23.4% versus 6.8%. These symptoms were especially common during the first two weeks of titration.

Why Does Vilazodone Cause Diarrhea and Nausea?

Serotonin has major functions in the gastrointestinal tract.

When vilazodone inhibits SERT:

1. Serotonin signaling in the intestine increases
2. GI serotonin receptors are stimulated
3. Intestinal secretion and motility may increase
4. Possible:

Diarrhea + nausea + abdominal discomfort

This is why gradual dose titration is particularly important with vilazodone.

Does Vilazodone Cause Sexual Dysfunction?

It can.

Possible symptoms include:

• Reduced libido
• Delayed orgasm
• Difficulty reaching orgasm
• Erectile dysfunction
• Ejaculatory problems In Canadian clinical trials, spontaneously and systematically measured sexual adverse effects were generally relatively low, although sexual side effects can still occur and may be underreported. For example, reduced libido was reported in about 3–4% of men receiving vilazodone versus less than 1% with placebo in the cited trials.

Vilazodone is sometimes promoted as having fewer sexual adverse effects than conventional SSRIs. There is some supporting clinical evidence, but cross-study comparisons should be interpreted cautiously, and vilazodone should not be described as free of sexual side effects.

Canadian labeling also notes reports of persistent sexual dysfunction after discontinuation with serotonergic antidepressants.

Does Vilazodone Cause Weight Gain?

It can, but substantial weight gain was not especially prominent in short-term trials.

In longer-term open-label treatment, the average weight increase at:

Week 52 was approximately 1.7 kg

among patients remaining in the study.

Individual responses vary considerably.

Weight may also be influenced by:

• Recovery from depression
• Appetite changes
• Activity
• Sleep
• Other medications
• Metabolic susceptibility

Can Vilazodone Cause Insomnia or Sleepiness?

Yes.

Some patients experience:

Insomnia or activation

while others experience:

Somnolence or fatigue

In short-term trials, insomnia occurred in approximately 6–7% of vilazodone-treated patients compared with about 2% receiving placebo.

The direction of the sleep effect therefore varies between individuals.

Can Vilazodone Initially Increase Anxiety?

Yes.

Early serotonergic changes can temporarily produce:

• Restlessness
• Anxiety
• Jitteriness
• Insomnia
• Agitation
• Akathisia-like symptoms This can occur before the nervous system has fully adapted to the medication.

If severe agitation, unusual behaviour or worsening mood develops after starting or changing the dose, it should be clinically assessed.

Can Vilazodone Cause Serotonin Syndrome?

Yes.

Serotonin Syndrome

is a rare but potentially life-threatening condition caused by excessive serotonergic activity.

Possible symptoms include:

• Agitation
• Confusion
• Sweating
• Fever
• Tremor
• Muscle rigidity
• Muscle twitching
• Clonus
• Hyperreflexia
• Diarrhea
• Rapid heart rate Risk increases when vilazodone is combined with other serotonergic medications.

Which Drugs Can Increase Serotonin Syndrome Risk?

Important serotonergic combinations include:

• Other SSRIs
• SNRIs
• Tricyclic antidepressants
• MAO inhibitors
• Tramadol
• Tapentadol
• Fentanyl and related opioids
• Methadone
• Dextromethorphan
• Lithium
• Triptans
• Tryptophan
• St. John’s Wort Such combinations are not all automatically prohibited, but they require medication-specific assessment and monitoring.

Vilazodone and MAO Inhibitors

Vilazodone must not be taken with: Monoamine Oxidase Inhibitors — MAOIs because of the risk of severe serotonin toxicity.

The Canadian monograph requires at least: 14 days between stopping an MAOI and starting vilazodone, and at least: 14 days after stopping vilazodone before starting an MAOI.

Relevant MAOI-type drugs can include:

• Phenelzine
• Tranylcypromine
• Linezolid
• Intravenous methylene blue depending on the clinical setting.

Can Vilazodone Increase Bleeding Risk?

Yes.

Serotonin contributes to platelet function.

When serotonin reuptake is inhibited:

1. Platelet serotonin uptake decreases
2. Platelet aggregation may become less efficient
3. Bleeding risk can increase

The risk may be greater when vilazodone is combined with:

• Aspirin
• Ibuprofen
• Naproxen
• Other NSAIDs
• Warfarin
• Antiplatelet drugs
• Other anticoagulants Canadian labeling specifically warns about this interaction.

Can Vilazodone Cause Low Sodium?

Yes.

Like other serotonergic antidepressants, vilazodone can be associated with: Hyponatremia often related to: SIADH

Risk is greater in:

• Older adults

• People using diuretics

• People who are dehydrated or volume-depleted Symptoms can include:

• Headache

• Weakness

• Confusion

• Memory difficulty

• Unsteadiness Severe hyponatremia can cause seizures, coma or other serious complications.

Can Vilazodone Trigger Mania?

Yes.

Like other antidepressants, vilazodone can precipitate: Mania or hypomania in susceptible patients.

In short-term MDD studies, mania/hypomania was reported in approximately 0.1% of vilazodone-treated patients; patients with known bipolar disorder had generally been excluded from those trials.

Possible warning symptoms include:

• Reduced need for sleep
• Racing thoughts
• Grandiosity
• Excessive energy
• Increased activity
• Impulsivity
• Unusually elevated or irritable mood Vilazodone is not approved for bipolar depression in Canada.

Antidepressants and Suicidal Thoughts

Canadian vilazodone labeling contains a serious warning regarding possible:

New or worsening behavioural changes and suicidal thoughts or behaviour

particularly after beginning antidepressant treatment or changing the dose.

Close clinical monitoring is recommended for worsening depression, agitation, hostility, impulsivity or suicidal thinking.

Can Vilazodone Affect the Eyes?

Rarely.

Vilazodone can cause pupil dilation and may trigger:

Acute Angle-Closure Glaucoma

in someone with anatomically narrow drainage angles.

Urgent assessment is required for:

• Sudden eye pain
• Redness
• Blurred vision
• Visual changes
• Swelling around the eye

Can Vilazodone Cause Seizures?

Seizures are uncommon, but antidepressants can lower seizure threshold in susceptible patients.

Vilazodone was not systematically studied in patients with seizure disorders, and Canadian labeling recommends caution in this population.

Does Vilazodone Affect the QT Interval?

A dedicated cardiac study found:mNo consistent or dose-dependent QTc prolongation

at therapeutic or supratherapeutic vilazodone doses.

Vilazodone did produce some heart-rate and blood-pressure changes, particularly at supratherapeutic exposure, but pooled short-term MDD studies showed mean cardiovascular changes similar to placebo.

This should not be interpreted as meaning cardiac risk is impossible, particularly in patients with significant cardiovascular disease or interacting medications.

Vilazodone Drug Interactions

One of the most important things to know about vilazodone is that its exposure can be strongly influenced by: CYP3A4 because CYP3A4 is the principal CYP enzyme responsible for vilazodone metabolism.

Strong CYP3A4 Inhibitors

Strong CYP3A4 inhibitors decrease vilazodone metabolism.

For example: Ketoconazole increased vilazodone.

Canadian labeling therefore states that the vilazodone dose should:

Not exceed 20 mg/day when used with a strong CYP3A4 inhibitor.

Examples of strong CYP3A4 inhibitors can include selected:

• Azole antifungals
• Macrolide antibiotics
• Antiviral medications depending on the specific drug and dose.

Strong CYP3A4 Inducers

Strong CYP3A4 inducers accelerate vilazodone metabolism.

For example: Carbamazepine reduced vilazodone systemic exposure by approximately: 45%

in an interaction study.

Although lower exposure could theoretically reduce effectiveness, the Canadian monograph does not recommend increasing vilazodone beyond the normal maximum, because safety experience above 40 mg/day is limited.

Other strong CYP3A4 inducers can include:

• Rifampin
• Certain anticonvulsants
• St. John’s Wort St. John’s Wort additionally increases serotonergic toxicity risk.

Vilazodone and Alcohol

The Canadian product monograph recommends: Avoiding alcohol during vilazodone treatment.

Alcohol can worsen:

• Depression
• Judgment
• Coordination
• Dizziness
• Sedation even when it does not substantially change vilazodone pharmacokinetics.

Vilazodone and Digoxin

Vilazodone increased digoxin exposure modestly in an interaction study.

Because digoxin has a: Narrow therapeutic range

Canadian labeling recommends: Monitoring when the drugs are combined.

Vilazodone Dosage in Canada

The usual Canadian adult titration is:

Treatment stage	Vilazodone dose
Days 1–7	10 mg once daily with food
After 7 days	20 mg once daily with food
If additional response is required and tolerated	Increase to 40 mg once daily after at least another 7 days
Usual therapeutic range	20–40 mg once daily
Maximum with a strong CYP3A4 inhibitor	20 mg/day

Canadian labeling recommends 20–40 mg once daily with food, with gradual titration from 10 mg to improve tolerability.

These are product-label recommendations, not individualized instructions for changing a prescription.

Why Must Vilazodone Be Taken with Food?

This is particularly important for vilazodone.

Taking vilazodone without food can reduce exposure substantially.

Vilazodone should consistently be taken with food because taking it fasting can substantially reduce the amount of medication absorbed and potentially reduce effectiveness.

This is one of the most important practical differences between vilazodone and many conventional SSRIs.

Should Vilazodone Be Taken at the Same Time Every Day?

Generally, yes. Vilazodone is taken: Once daily with food and consistent timing and meal conditions can help produce more consistent drug exposure.

If the medication causes insomnia, morning administration may sometimes be preferred; if it causes sleepiness, timing can be individualized with the prescriber.

What Happens if a Vilazodone Dose Is Missed?

Canadian patient information advises taking the missed dose when remembered unless it is nearly time for the next dose.

Patients should:

Not take two vilazodone doses at the same time.

Does Vilazodone Need to Be Tapered?

Generally:

Yes.

Abrupt discontinuation can cause symptoms such as:

• Dizziness
• Irritability
• Anxiety
• Agitation
• Insomnia
• Headache
• Emotional lability
• Sensory disturbances
• Electric-shock sensations
• Tinnitus Canadian labeling recommends:

Gradual dose reduction rather than abrupt discontinuation whenever possible.

There is no universal tapering schedule; reduction should be individualized according to dose, treatment duration and previous withdrawal sensitivity.

How Long Does Vilazodone Stay in the Body?

Vilazodone has a terminal elimination half-life of approximately: 25 hours and steady state is generally reached within about: 3 days of once-daily dosing.

Maximum blood concentrations typically occur approximately: 4–5 hours after administration.

Frequently Asked Questions About Vilazodone

Is Vilazodone the Same as Viibryd?

Yes.

Viibryd is the best-known brand name for vilazodone. It remains marketed in Canada, along with generic vilazodone products.

Is Vilazodone an SSRI?

Partly.

Vilazodone inhibits SERT like an SSRI, but it also:

Partially activates 5-HT1A receptors.

It is therefore more accurately described as a:

Serotonin-modulating antidepressant with SSRI and 5-HT1A partial-agonist activity.

What Is a SPARI?

SPARI means:

Serotonin Partial Agonist-Reuptake Inhibitor

and is sometimes used to describe vilazodone’s combination of:

SERT inhibition + 5-HT1A partial agonism.

Does Vilazodone Increase Serotonin?

Yes, indirectly.

It inhibits serotonin reuptake and also acts directly at 5-HT1A receptors.

Does Vilazodone Increase Dopamine?

Not significantly through direct dopamine-transporter inhibition. Its main pharmacology is serotonergic.

Does Vilazodone Increase Norepinephrine?

Not significantly through NET inhibition. It is not an SNRI.

Why Must Vilazodone Be Taken with Food?

Because fasting can reduce vilazodone exposure by approximately 50%, potentially reducing treatment effectiveness.

Does Vilazodone Cause Diarrhea?

Frequently, particularly during initial titration. Diarrhea occurred in approximately 28% of vilazodone-treated patients in pooled short-term trials.

Does Vilazodone Cause Sexual Dysfunction?

It can. Clinical-trial rates were relatively low, but reduced libido, erectile dysfunction, ejaculatory problems and orgasm difficulties were reported.

Does Vilazodone Cause Weight Gain?

Some patients gain weight. In a 52-week study, average weight gain among patients remaining at week 52 was approximately 1.7 kg.

Does Vilazodone Need to Be Tapered?

Usually yes. Gradual reduction is recommended rather than abrupt discontinuation whenever possible.

Which Enzyme Metabolizes Vilazodone?

The main enzyme is: CYP3A4 with minor contributions from CYP2C19 and CYP2D6.

Does CYP3A4 Genotype Determine Vilazodone Dose?

No.

There is currently no validated genotype-based CYP3A4 dosing recommendation for vilazodone.

Do Strong CYP3A4 Inhibitors Matter?

Yes.

Canadian labeling limits vilazodone to: 20 mg/day when combined with a strong CYP3A4 inhibitor.

Can SLC6A4 Predict Vilazodone Response?

Not reliably enough for routine prescribing.

SLC6A4 encodes vilazodone’s SERT target, but current evidence does not support genotype-guided antidepressant treatment based on SLC6A4 alone.

Can HTR1A Predict Vilazodone Response?

Not yet.

HTR1A is particularly biologically relevant because 5-HT1A is a direct vilazodone target, but no validated HTR1A-guided prescribing recommendation currently exists.

References

• [https://health-products.canada.ca/dpd-bdpp/search-fast-recherche-rapide?code=15353&lang=eng&lang=eng)
• [https://health-products.canada.ca/dpd-bdpp/search-fast-recherche-rapide?code=3636&lang=eng&lang=eng)
• https://pdf.hres.ca/dpd_pm/00077084.PDF
• [https://pmc.ncbi.nlm.nih.gov/articles/PMC10564324/)